current user: public
If you have questions about the server, please let us know.

Query: PF05088.12; A4XWG7_PSEMY/77-1608; Bacterial NAD-glutamate dehydrogenase, from PfamA32U

Results of FFAS03 search in PfamA32U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070    . 1080    . 1090    . 1100    . 1110    . 1120    . 1130    . 1140    . 1150    . 1160    . 1170    . 1180    . 1190    . 1200    . 1210    . 1220    . 1230    . 1240    . 1250    . 1260    . 1270    . 1280    . 1290    . 1300    . 1310    . 1320    . 1330    . 1340    . 1350    . 1360    . 1370    . 1380    . 1390    . 1400    . 1410    . 1420    . 1430    . 1440    . 1450    . 1460    . 1470    . 1480    . 1490    . 1500    . 1510    . 1520    . 1530
# Score Template Links and tools%idFirst VRAFNPDYEKHGWQSTHTAVEILHGDIPFLVDSVRMELNRRGYSIHTLQNSVFSVRRDANGELLEILPRGTQGEGVLQEALMFLEIDRCSSSAELKTLEKAIHEVFGDVRMSVADFQPMKAKARELLAWLDRAKLKVDKAELEEIKVYLNWLLDNHFTFLGYEEFTVAPSADGGTMVYDEKSLLGLSKRLRTGLTAEELHIEPEAVAYLREPQLLSFAKAAVPSRVHRPAYPDFVSIRELDAKGNVVKECRFMGLYTSAVYAESVWNIPYIRRKVDVIKQRSGFDSSAHLGKELAQVLEVLPRDDLFQTPVDDLFNTALAIVQIQERNKIRVFLRRDPYGRFCYCLAYVPRDVYSTETRLKIQQVLMDRLQATDCEFWTFFSESVLARVQFILRVDPKNKTQIDPVRLEKEVIQACRSWKDDYASLMVESFGEAQGTNVLAEFPGGFPAGYRERFAPHSAVVDMQHLLSLSNDKPLVMSFYQPLAQGDQQLHCKLYHADTPLPLSDVLPILENLGLRVLGEFPYKLRRNDGREFWIHDFAFTYAEGLDVDIQQLNDTLQDAFIHIVGGDAENDAFNRLVLIAAMPWRDVALLRAYARYLKQIRLGFDLSYIASTLINHADIAKELVRLFRTRFYLARKLTAEDLEDKQQKLEQAILAALDNVAVLNEDRILRRYLDLIKATLRTNFFQADASGAAKSYFSFKLSPRLIPEIPRPVPKFEIFVYSPRVEGVHLRFGDVARGGLRWSDREEDFRTEVLGLVKAQQVKNAVIVPMGAKGGFVPRKMPVGGSRDEVMAEGIACYRIFISGLLDITDNLKEGEVVPPVNVVRHDADDPYLVVAADKGTATFSDIANGIAAEYGFWLGDAFASGGSAGYDHKGMGITAKGGWVSVQRHFRERGIDVQKDNVTVIGIGDMAGDVFGNGMLLSDKLQLVAAFNHMHIFIDPNPDAAKSFAERKRLFDLPRSSWADYDSKLISEGGGIFLRSAKSITITPQMKARFDIAADKLAPTELLNALLKAPVDLLWNGGIGTYVKSSKESHADVGDKANDALRVDGRELRAKVVGEGGNLGMTQLGRVEFGLHGGASNTDFIDNAGGVDCSDHEVNIKILLGEIVSGGDMTEKQRNKLLAEMTDDVSELVLGNNYKQTQALSLAERRARERVGEYKRLMNALESAGKLDRALEFLPSDEELNERATNGQGLTRPELSVLISYSKIDLKESLLKSLVPDDDYLAREMETAFPEILTEKFGDAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSAANVAGAYVIVRDLFRLPHWWAQIEALDYKVPAELQLQLMDELMRLGRRATRWFLRSRRNELDAARDVAHFAPRIEALVGRLDELLEGPAREQWLARYQSFVEAGTPEELARVVAGTSHLYTLLPIIEAADVTGKDASEVATAYFAVGGALELSWYLQQITNLPVETNWQALAREAFRDDLDWQQRAITVSVLQMAEGPQEIEARVALWLEQHHRLVERWKAMLTELRSATGTDYAMYAVANRELMDLast
1 -344.000PF05088.12; A4XWG7_PSEMY/77-1608; Bacterial NAD-glutamate dehydrogenase  ali  100  1VRAFNPDYEKHGWQSTHTAVEILHGDIPFLVDSVRMELNRRGYSIHTLQNSVFSVRRDANGELLEILPRGTQGEGVLQEALMFLEIDRCSSSAELKTLEKAIHEVFGDVRMSVADFQPMKAKARELLAWLDRAKLKVDKAELEEIKVYLNWLLDNHFTFLGYEEFTVAPSADGGTMVYDEKSLLGLSKRLRTGLTAEELHIEPEAVAYLREPQLLSFAKAAVPSRVHRPAYPDFVSIRELDAKGNVVKECRFMGLYTSAVYAESVWNIPYIRRKVDVIKQRSGFDSSAHLGKELAQVLEVLPRDDLFQTPVDDLFNTALAIVQIQERNKIRVFLRRDPYGRFCYCLAYVPRDVYSTETRLKIQQVLMDRLQATDCEFWTFFSESVLARVQFILRVDPKNKTQIDPVRLEKEVIQACRSWKDDYASLMVESFGEAQGTNVLAEFPGGFPAGYRERFAPHSAVVDMQHLLSLSNDKPLVMSFYQPLAQGDQQLHCKLYHADTPLPLSDVLPILENLGLRVLGEFPYKLRRNDGREFWIHDFAFTYAEGLDVDIQQLNDTLQDAFIHIVGGDAENDAFNRLVLIAAMPWRDVALLRAYARYLKQIRLGFDLSYIASTLINHADIAKELVRLFRTRFYLARKLTAEDLEDKQQKLEQAILAALDNVAVLNEDRILRRYLDLIKATLRTNFFQADASGAAKSYFSFKLSPRLIPEIPRPVPKFEIFVYSPRVEGVHLRFGDVARGGLRWSDREEDFRTEVLGLVKAQQVKNAVIVPMGAKGGFVPRKMPVGGSRDEVMAEGIACYRIFISGLLDITDNLKEGEVVPPVNVVRHDADDPYLVVAADKGTATFSDIANGIAAEYGFWLGDAFASGGSAGYDHKGMGITAKGGWVSVQRHFRERGIDVQKDNVTVIGIGDMAGDVFGNGMLLSDKLQLVAAFNHMHIFIDPNPDAAKSFAERKRLFDLPRSSWADYDSKLISEGGGIFLRSAKSITITPQMKARFDIAADKLAPTELLNALLKAPVDLLWNGGIGTYVKSSKESHADVGDKANDALRVDGRELRAKVVGEGGNLGMTQLGRVEFGLHGGASNTDFIDNAGGVDCSDHEVNIKILLGEIVSGGDMTEKQRNKLLAEMTDDVSELVLGNNYKQTQALSLAERRARERVGEYKRLMNALESAGKLDRALEFLPSDEELNERATNGQGLTRPELSVLISYSKIDLKESLLKSLVPDDDYLAREMETAFPEILTEKFGDAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSAANVAGAYVIVRDLFRLPHWWAQIEALDYKVPAELQLQLMDELMRLGRRATRWFLRSRRNELDAARDVAHFAPRIEALVGRLDELLEGPAREQWLARYQSFVEAGTPEELARVVAGTSHLYTLLPIIEAADVTGKDASEVATAYFAVGGALELSWYLQQITNLPVETNWQALAREAFRDDLDWQQRAITVSVLQMAEGPQEIEARVALWLEQHHRLVERWKAMLTELRSATGTDYAMYAVANRELMD 1532
2 -20.900PF00208.21; DHE3_ORYSJ/176-408; Glutamate/Leucine/Phenylalanine/Valine dehydrogenase  ali follow..  17  1...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GGSLG----RDAATGRGVMYATEALLTEYSESISGSTFVIQGLGNVGSWAA--KLIHQKGGKIVAVGDVTGAIRNKSGIDIPALLKHRSEGGSLEDF----------------------------------YGAEVMDAAELLVH------------ECDVLVPCALG---------GVLNRENAAEVKARFIIEGANHPTDTEADEILAKKGVIVLPDIYANSGGVVVSYFE------WVQNIQGFMWDEEKVNRELQKYMKNAFQNIKDMCKSQNCNL-----RMGAFTLGVNRVAKATLLRG........................................................................................................................................................................................................................................................................................................................................................................ 233
3 -13.500PF02812.18; R6WCN3_9CLOT/34-162; Glu/Leu/Phe/Val dehydrogenase, dimerisation domain  ali follow..  28  21......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FEGFRIQHSTLAKGGVRYHQNVN--VDEVRALSAWMTFKCAVIPYGGGKGGIVCRP------REMSKGELERLTRTYIDKISAIISPNTD-------------------IPAPDVGTNA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 117
4 -8.130PF02514.16; Q2JMZ0_SYNJB/187-1302; CobN/Magnesium Chelatase  ali follow..  11  68......DLPEEVKDPLAPCVGLVLQRTHLVYVAMVQELESRGARV-----PVFAGGLDFSKPVNEFFWNAQKT--------------------------APIVDVVVSLTGFALVGGPARQDHPKAVEALQRLNRPYMVALPLVFQSTEEWAASDL----GLHPVQVALQIAIPELD-------GAIDPIILSGRDAATGKAHAMQDRIELIAARAIKWANLRRKPKLEKKIAITVFSFPPDKGNV---------------TAAYLDVFASIHRVMQALAHNGYDLGPELPKTPQELMESILHDPQAQYASPELNVAAKLSVREYEALTPYVKAIEQYWGPAPGHLNTDGQNLLIYGKHFGNVFIGVQPTFGYEGDPMRLLFSRSASPHHGFAAYYTYLEKVWGADAVLHFGTHGSLEFMPGKQIGMSGE--------------------------PDNLIGSLPNLY-ANNPSEATIAKRRGYACTISYLTPPAENAGLYKGLQELREMIGSYQTLREGARGIAIVNAICDKARLVNLDKDVDLPAGDAAQLSLEERDTVVGKIKLMEIESRLLPCGLHVIGAPPTAEEAIATLVSIASIDRPEEGILGLPRILAQSLGRDIDEIYRNRDRGHLADTELLDRINKACQKAVAALVQEQTDAQGRVSRVAKLNFFNMGRQAPWLAVLKEAGYPQVDPDLLKPLFEFLEECLKQITADYELGSLLRALEGEYILPGP---GG--------------------DPIRNPNVLPTGRN------------------------IHALDPQSIPTAAAIKSAEIVVERLLAREMSSNG----GKYPETISVVLWGTDNIKTYGESLAQVLC-----------LGVDALGRVNKVELILEELGIDV------VVNCSGVFRDLFVNQMLIDRAVKLAAAAVEKHALQQAEELGLTLEQAATRVFSNASGSYSELREMYLSRKSFAFGSNLPNQQMRQLFEASLTVDVTFQNLDSSEISLTDVSHYFDADPTKLVQSLDGKAPSAYMADTTTPNAQIRRLDARTKLL----N-----EGMLKHGYEGVREIAKRLVNTSGWSATAGAVD-----------------------NWIYEETNETFIKDEAMRQ---RLMNLNPHSFRRIVGSLLEVHGR.......................................................................................................................................................................................................................................................................................................................................................................... 1106
5 -7.830PF10266.9; H2R9P1_PANTR/23-1103; Hereditary spastic paraplegia protein strumpellin  ali follow..  12  1........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NAIIAELLRLSEFIPAVFRLKDRADQQKYGDIIFDFSYFKGPEL---ESKLDAKPELQDLDE------------FRENNIEIVTRFYLAFQSVHKYIVDLNRYLDDLNEGVYIQQTLETVLLNEDGK---------------------LLCEALYLYGVMLLVIDQKIEGEVRERMLVSY-----YRYSAARSSADSNMDDICKLLRSTGY-----------------SSQPGAKRPSNYPESYFQRVPIN---ESFISMVIGRLSDDIYNQVSAYPLPEHRSTALANQALYFEPSILHTHQAKMREIVDKYFPDNW------VISIYMGITVNLVDAWEPYKAAKTALNNTLDLSNVREQASRYATVSERVH--AQVQQFLKEGYLREEMVLDNIPKLLRDCNVAIRWLMLHTADSACDPNNKRLRQIKDQILTDSRYNPRI--LDTAQFEFILKEMFKQMLSEKQTKWEHYKKEGSERMTELADVFSGVREISKQILSLNYDDSTAAGRKTVQLIQALEEVQEFHQLESNLQVCQFLAD--------TRKFLHQMIRTINIK-EEVLITMQIVGDLSFAWQLIDSFTSIMQESIRVNPSMVTKLRATF-LKLASAL--------LLRINQANSPDLLSVSQYYSGELVSY-VRKVLQIIPESMFTSLLKIIKLQTHDIIEVPTRLDKDKLRDRYEVAKLTHAISIFTEGILMMKTTLVGII--------KVDPKQLLEDGIRKELVKRVAFALHRGLIFELMPKLKELGATMDGFHRSFEYIQDYVNIYGLK-----------WQEEVSRIINYNVEQECNNFLRTKIQDWQSMYQSTHIPIPKFTPVDESVTFIGRLCREILRITDPKMTCHIDQLNTWYD 826
6 -7.780PF11894.8; C5DMA7_LACTC/4-1647; Nuclear pore complex scaffold, nucleoporins 186/192/205  ali follow..  8  49......................LEKGQIKVPSGDTYQINQEFAIAAITLSDELNLDELLTAEIMLQNCDLDSVSENSVISLVNDAK------VRRQYILQIVSFITNCAKNIIPAFKQIESQLGEIKVLVNKSAILESYDTFQQNVRFRRDFLLKEYDTLSQILYGLVKNG-----TLMKKDMLLELIN-----CASMMDSGDFFIIYFLPALFLAISQLHLLPDGHVREMHQTLLLELESDTISVQPVKASLIFAFLAFFIGWCKAAPSQRAKSFNFATDVDEPMTKAVELGAIEQLMAFAADTSELDKDESIELFYDIRSLLERHIPRLYLKQLVDGDQPSPDAINNQRLLTNASMSQQSLSFFLSAFHHLLQVV---------------------------ITDCAFLLTKMKDAEEDSLLSGEDLFLDEISAKADLERFFITVHYFYAKCTDTLMRSCVFMMLSSLSFGPENSANVYH------------YVNLNANLSWNTVSQLISDY----IVKISELERKLLDGQQRDREEQDPTTIALKTGLNEEVIILLSSLYTLIGCVAHDLNFEFVKVDTPLVGAALKVLSNLVPFRLTISDDSYREAFESILTHFQD-ITGFLQLLNSLLKVRTKSTNGYLEFGLLQFPPKLGHVFHGINPAERAAIHKPILEILSSALSSDYSVILNSIPSGSNLDELVVTDNFLTYAMESSTTAVYLFEENVFKNLLQNASFGVEKMGSITEEDCQSLALP-VLTIQETYVEELCPKKSASKNYFIPKDFGLHGLRSFYDAISFDLPLIVGIGLYVGHTNYKIASNSLDILDKISTEMKGRDSQAIVKDKLLSVFDSVDES------ARIKQAFINQLQTSITNYESFSIKMRILDFISKLGLQIGNTISLGPDLSTFVTSGCS-TSIIYLLQSSLMVLSSEEIEFLPAKLASSSMEILLKLCKNSATS-SDFFETILARDPKVDVNTRWSGEVFAGNSAGDSLGFIKQTSTGAFLSFLSYRSFALQYLSLDIHGLSGESLKSRIKSRIDLLISNYLQPPRLFSFLDALNFDARPSPHETLSGINFNLPSLQKVTPCTELIYDCSELESLILNFHEETITNKETLDRISGAEAATIEKHLTDYMSFEQFKSLQLSLLHSWVQLVQVVVLDGALPQVSISDFILRLF---EAIVPKINDYVELDVCYSEELVSLCVFLYDLYQKDQKLNNGEHTADGRLIALFLACINGIRSPLSTLALRSDFYILANRFLVSIMKEVNTAKQVLKTLKLTSERLVE--VVCNDAISGEGSSRGILFLDSLVQIAGLNKVNFVLESLVKS----------------NMLLLISHSIKTTDDLLSSGLEGITLDNFKSTIHFLIRIAESRSGAQALVE----NEIFRVIESCEFLEADPDLGLELIFTEVRTQESQAVRVTFSLDKSLNLSKDACGLSLFEIIVPVFQLMTSILISMGSANKPVLKKTRNLLIHFRKLVQGVLKRDALIEGSDEKHLDRSNSGLQKL.. 1633
7 -7.550PF17072.5; SPIKE_BRV1/1-1583; Torovirinae spike glycoprotein  ali follow..  10  202............................................................................................................................................................YQITPYTQYTVTMPSGTSGYCQQTPLYVECGSWTPYRVHAYGCDKATQSCNYTISSDWVVAFKSKASAIILRSQLIVALAQKLSRTVG-VNKAVYFWFLKQPYHYLSLVNFSPALFSPLCKSLRQQSATYSALSYGSPFFVAQECYNNALYLPD-------LYTLFSILFSWDYQVNYPVNNVLQANETFLQLPTTGYQTVSQGRMLNLFKDAI--DFYDTKFYRTNDGPGGDIFAVVVKQVPVIAYSAFRIEQQTGYLAVKCNGVIQATLAPHSSR---VVLLARHMSMWSIAAANSTTIYCPIYTLTSFVRLDISTSWYFHTLAQPSGPIQQVSMPVLSTGAAAQSSVYQPSMFNMGVNKSVTLTTQLQAYAQTAWFLSILYTRLPESRRLTLGAQLTPFIQALLSFKQADIDATDVDTVARYNVL-----KYAAVIYNQLPEWSYPLFKGGVGDSMASHFPFIAGYLDFLDYKYIPKYKDVACPLSTMVPSILQVYET--------------QLFVIIVQCVSTTYSWYPGLRNPHTIYRSYKLGTICV--VPYSSPTDVYSSFGFFFQSA--TTDDILPGCVGFVQDSVFTPCHPSGCPVRNSYDNYIICPGSSASNYTLRNYYRTTTPVTNVPIEEVPLQLEIPTV-----SLTSYELKQSESVLLQDIEGGIVV---DHNTGSI-----------GQAYDVSFYVSVIIRYAPPKLELPSTLANFTSCLDYICFGNQQCRGEAQTFCT---SMDYFEQVFNKSLTSLITALQDLHYVLKLVLPETTLELTEDTR---RRRRAVDEFSDSLLSESGISLPQRTGSILSSAPSLSSISSWHSYSSRTPLISNVKTPKTTFNVKLSMPKLPKAST---STIGSVLSSGLSIASLGLSIFSIIEDRRV-------IELTQQQIMALEDQITILAGYTTKNFEEIQSSLVQDFSQTSALSLQQLSNGFEQITQQLDKSIYYVMAVQQYATYMSSLVNQKTQDMYITCIHSLQSGVLSPNCITPFQICHLYQVAKNLSSGECQPILSISRFYSLPLVTDAMVHNDTY--SNILGSVYKVQPGYIVNPHHPTSLQYDVPTHVVTSNAGALIFDEHYCDRYNQVYLCTKSAFDLAEASYLTM............................................................................................................................................................................................................................................ 1383
8 -6.420PF00946.19; Q6YIR9_FDLV8/10-1113; Mononegavirales RNA dependent RNA polymerase  ali follow..  9  333........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GSVSEISEIFSFFRSFGHPVLEAVTA---------ADKVRDHMCKPKVLDYETLQKGHAVFCSMIIN-GFRERHG----------GSWPPCFLPDYASSELKAVMANHAAIPYELSVNNWESFIGFKFDKFEE--VNLDEDL--TIFMKDKALSPIRAEWDTVYPQENMQYSPGRSSTS-----RRLVDVFLE-------DMEFNPQDIIDYVVSGSYL--IDQDFNISYSLKEKEIKQA-----GRLF--AKMTYKMRAAQVLAESLVAHGVGKYFQENGMVKDEHELLKSLTTLSLAGVPRSRPGEDPSATEESKFVKIAQKGKEILRNNQTRRSTQESRDQDGLANEKHETVASFQKFCLNWRYESVILFAQRLDEIYGLPGFFEWLHKRLEKSV-----------ADPNCPPDFRTKMSLEDTPDTGIFIHNP--------MGGIEGYSQKMWTIISISMIHLAAVQTGVRVSAVIQGDNQSIAVTTRVPV---RMNYNQKKTECYKSTIRYFETLRKVMGGLGHNLKLNETIISNQFFIYSKYFDGSILPQGLKTISRCVFWSETCSNISTSLAKAVENGISPLLCYLLNAWTKDLYGPILSSQDWMIIAV--IVPSQL---FNYMSLSRLFVRN-IGDPLVAAL------ADVKRYIEIGLLTTAALTKFTTQVPGDSTELDWASDPYSANLPHSQSVTTVIKHVTARSVLSKSPNPMLEGLFHENTDEEDHDLARFLIDREIILPRVANVILDQSVTGARSAIAGL----DTTKTLIKNTANKGGLSNRTVSKLLYHDYQQFIVFNKIL.................................................................................................... 1104
9 -6.300PF15962.5; A9MQT6_SALAR/12-1138; Domain of unknown function (DUF4765 topsan)  ali follow..  10  8..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TKGIKTWDTIQYLSALDRAHKDTV----FHEQISNLPEEYIHL--DEMARDEKEYGLNIYEFFFESTALDFYYLKSPTFRR--VNYTSKCEVIVSPNYSYQNTEGSSVYLSLPFDKKGFPI---NPESNDCDNNISSEKVLLDLFLKHILYDDLKVDHEVTNLYSNVI-------------------YKEIDSTAMAHASLCFSQAAVSDKHELFNIDSVTVQPKSTEQVIKQILFFFERENNFQPATAHKMERNIKNIAVTGLLLSSRLTIADGYG----RKNDNSENKNNFSSDKEPLRYARALPEDHPAPNMEPHGKMIDGIVEHSSFAAGISLFETLKK--IGDEQLMNDYKRGYHELLVFSQTGQWTH-------------------GGRRLTAEYMFNGLIIHL-NEIEILINDGGKVSFEHFVREHIEHQYKIYELIARMLVHPIYIRSRIFATRRIASALANESHYTK-VLNQKFPEISSSNFDTFYGKEAIFTALKIVNYYREEKGMSKKMKDLFKRVQLVIRHLSRNGGDKILLSPDGIKYNFSIMRNIIYWCAKITGPVNDKKINALSRKIVVNNETHVKDHIQDCDVLGLMNINKMLRDTVVGLIHEISDIAQSS---LTAEDQHEKQVQALEAFKSKVSSMDG-------QAFVYGFDKVIQEGLWGLI---------------------ELSFDIDDTVHHRTVSSLSASRAGLHFLGTIWNIV--MSFVPGFNALAGTSSILNRAIVEKSTDVCGYIQDVIRIGMEAA-------VAEAKFTERASNAKYTGLRFVENKIERGVIRSPIQKGSNYKVIES-IENIDFIYQKRNNKILELNPEGNDGLYRAT........ 853
10 -6.050PF03429.13; B9KHR1_ANAMF/1-756; Major surface protein 1B  ali follow..  13  5...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DKQQQQNQSDVVQAISAVFQELQRLNDFIKGADGTLKEALSKQLSEKIAAEAAAKA--------DAKYESVGLRAKAVARGKLKSSDAPKDLDQSIDAL-EAPDTGEKIEVPAGEEQEF------------KAAAWGLAGFKRTVDESLEML----------------------------DRGMHMLAEGQAQISQ----------------GIDAKDTALVREGL------ETSRLGAGLCRNGLVEASYGETMGKYAGKGLALEEIESLRTAIDAKGEAWSPEGVSANTFYKGLHKIGTAIAVAAQATWEGLAMTGKFMGAVAKAVSMCVAAYTAAIVGMAAATPATLLLTAMDNQSVNNAVVKVSEYLHSNVEQATKDLMASEFAMMTFGGIMTCAKLMKGSFAAINQK----FEEINATLTREATDIAQGVKETYQSIG---AFGNAFKSVGDAFKSIGDAFKSANDGIAKWTAALAGYASVEQLEEAKEADRVQAEQRAEAQAMTERVAGERAATVAAGTETIKTIVSD----MRNELAEQLQLVITDMCNELAQIGAFSQAERDALVKSFTPKPPARTTKELISHMHSGLESVMFRMARSIMSKASIEANSQDNSVEVAEISPETQNMSDAIPVEEAQIVETALLAAVNDTSKDDQAIVTDLINATIEVCTEQTNTLAGHTAEVQAGLEAAGIRFDDAQGLQEATPEAKGVEGINQEELEQAAEGLAAAVNEASA.................................................................................................................................... 727
FFAS is supported by the NIH grant R01-GM087218-01
1 4 6 8 5 0   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Plewczynski D, Tkacz A, Godzik A., Rychlewski L. A support vector machine approach to the identification of phosphorylation sites. Cell Mol Biol Lett. 2005;10(1):73-89.